Study of susceptibility to Maxaquin of clinical strains of microorganisms isolated in patients with wound and burns infections
About the Authors
L. A. GrishinaRussian Federation
L. S. Puchkova
Russian Federation
V. P. Yakovlev
Russian Federation
References
1. Кузин М .И ., Колкер И .И ., Костюченок Б .М . и др. Бактери ологическая диагностика раневой инфекци и: Метод, рекомендации .— М., 1984.
2. Навашин С .М ., Фомина И .П . Р ациональная аптибиотикогерапия.— М., 1982.
3. Inderlied С .Б., Lancero M .G ., Bermudez L .M ., Young L.S. In vitro activity of Lomefloxacin as Compared with Ciprofloxacin //Diagnost. Microbiol.Infect.Dis.— 1989.— Vol. 12, N 3.— Suppl.— P. 17S— 20S.
4. Sonstein 5.Л ., Dahlgren J. In vitro activity of Lomefloxacin (SC47111 or N Y -198), a new quinolone antim icrobial, against clinical isolates of common pathogens / / Ibid.— P. 21S— 28S.
5. Torres J.R. Antimicrobial activity of Lomefloxacin (NY-198, SC47111) against bacterial strains from Venezuela / / Ibid.— P. 41S— 44S.
6. . Trujillo II.y Castrillon de P., Gomez C. In vitro evaluation of lomefloxacin activity in Colombia / / Ibid.— P. 51S— 52S.
7. Wright D .N .y Saxon B .t Matsen J.M . Comparative in vitro activity of Lomefloxacin (SC47111 or N Y -198) against fresh clinical bacterial isolates / / Ibid.— P. 7S— 12S.
Review
For citations:
Grishina L.A., Puchkova L.S., Yakovlev V.P. Study of susceptibility to Maxaquin of clinical strains of microorganisms isolated in patients with wound and burns infections. PULMONOLOGIYA. 1993:42-44. (In Russ.)